Half yearly performance report - January to June 2015
The half yearly performance report
This half yearly performance report covers the period 1 January to 30 June 2015 inclusive.
Future reports will be published annually, with the next report covering July 2015 to June 2016. This is in line with the report against the TGA key performance indicators and measures: Regulator Performance Framework.
The KPI report outlines performance against our broad strategic intent, and should be read in conjunction with the performance statistics provided in the future copies of this report.
About the TGA
The Therapeutic Goods Administration (TGA) is part of the Australian Government Department of Health, and is responsible for ensuring that therapeutic goods available for supply in or exported from Australia are safe and fit for their intended purpose. We regulate the import, supply, export, manufacture and advertising of therapeutic goods including:
- medicines: prescription and over-the-counter medicines, vaccines, complementary medicines, and blood and plasma products
- medical devices: which includes a wide variety of products ranging from lower risk items like adhesive bandages through to higher risk devices like pacemakers
- biologicals: stem cells, tissues and cell based products.
For more information about the type of products we regulate, and how the regulatory system works, please visit the TGA basics section of our website.
|Version||Description of change||Author||Effective date|
|V1.0||Original publication||Reporting and Collaborative Services||December 2015|